Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4327 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Heme-Oncology |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Heme-Oncology Peripheral Blood Mononuclear Cells are a type of mononuclear cell population derived from peripheral blood, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. Peripheral blood from patients with hematologic oncology conditions (e.g., leukemia, lymphoma, myeloma) .Round mononuclear cells; suspension growth; weak/no adhesion
.PBMCs play an important role in immune regulation: T/B cells mediate adaptive immunity (antigen recognition, antibody production), NK cells perform natural killing functions, and monocytes can differentiate into macrophages or dendritic cells, participating in antigen presentation and inflammation regulation. PBMCs themselves are non-tumorigenic, but may include malignant cells in the hematologic cancer context. PBMCs reflect immune dysregulation in hematologic cancers, influencing tumor immune escape, inflammation, and immune surveillance.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Heme-Oncology Peripheral Blood Mononuclear Cells can be used to study the pathogenesis of hematological malignancies such as lymphoma and leukemia, evaluate drug efficacy, and develop new treatment strategies. For example, when evaluating new antibody drugs for hematological tumors, they can be used as effector cells to detect the antibody-dependent cellular cytotoxicity (ADCC) activity of antibodies